Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Feature
  • Published:

Genetic engineering to enhance microbial interference and related therapeutic applications

Nature Biotechnology volume 14, pages 444–447 (1996)Cite this article

Can biotechnology augment competitive exclusion for novel therapeutic approaches?

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. This literature review was performed while at the Naval Medical Research Institute, Bethesda, MD, and does not represent the official views of the U.S. Government.

  2. Bibel, D.J. Bacterial interference, bacteriotherapy, and bacterioprophylaxis. In: Aly R., Shinefield H.R., (eds.). Bacterial Interference. CRC Press, Boca Raton, Florida.1982:1–12.

    Google Scholar 

  3. Fleming, A. History and development of penicillin. In: Penicillin: Its Practical Application. Fleming A., editor. Philadelphia: Blakiston, 1946:1–33.

    Google Scholar 

  4. Jakab, G.J. Mechanisms of bacterial superinfec-tions in viral pneumonias. Schweiz Med Wochen-schr 1985; 115: 75–86.

    Google Scholar 

  5. Gremillion, D.H., Crawford, G.E. easles pneumonia in young adults. An analysis of 106 cases. Am. J. Med. 1981; 71: 539–42.

    Article  CAS  Google Scholar 

  6. Joklik, W.F., Willett, H.P., Amos, D.B., Wilfert, C.M., (eds.). Zinsser Microbiology. 20th ed., Norwalk, CT: Appleton & Lange, 1992: 395–8.

  7. Shinefield, H.R., Ribble, J.C., Boris, M., Eichenwald, H.F. Bacterial interference: its effect on nursery acquired infection with Staphylococcus aureus . Am J Dis Child 1963; 105: 646–54 and 683–8.

    CAS  PubMed  Google Scholar 

  8. Houck, P.W., Nelson, J.D., Kay, J.L. Fatal septicemia due to Staphylococcus aureus 502A. Am J Dis Child 1972; 123: 45–8.

    Article  CAS  Google Scholar 

  9. Sprunt, K., Leidy, G. The use of bacterial interference to prevent infection. Can J Microbiol 1988; 34: 332–8.

    Article  CAS  Google Scholar 

  10. Calculated from: Protein data (Bacterial cells: E. coli or Salmonella typhimurium). In Reference appendix. New England Biolabs 1993/94 catalog. Beverly, MA: New England Biolabs, 1993: 207.

  11. Sahl, H.G. Bactericidal cationic peptides involved in bacterial antagonism and host defence. Microbiol Sci. 1985; 2: 212–7.

    CAS  PubMed  Google Scholar 

  12. Scully, B.E., Briones, F., Gu, J.W., Neu, H.C. upirocin treatment of nasal staphlococcal colonization. Arch Int Med 1992; 152: 353–6.

    Article  CAS  Google Scholar 

  13. Kolenbrander, P.E., Ganeshkumar, N., Cassels, F.J., Hughes, C.V. Coaggregation: specific adherence among human oral plaque bacteria. FASEB J 1993: 7: 406–13.

    Article  CAS  Google Scholar 

  14. Johnson, K.P., Hillman, J.D. Competitive properties of lactate dehydrogenase mutants of the oral bacterium Streptococcus mutans in the rat. Arch Oral Biol 1982: 27: 513–6.

    Article  CAS  Google Scholar 

  15. Tanzer, J.M., Kurasz, A.B., Clive, J. Competitive displacement of mutans streptococci and inhibition of tooth decay by Streptococcus salivarius TOVE-R. Infect Immun 1985; 48: 44–50.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Hillman, J.D., Dzuback, A.L., Andrews, S.W. Colonization of the human oral cavity by a Streptococcus mutans mutant producing increased bacteriocin. J Dent Res 1987; 66: 1092–4.

    Article  CAS  Google Scholar 

  17. Lehner, T., Ma, U.K., Kelly, C.G. A mechanism of passive immunization with monoclonal antibodies to a 185,000 M(r) streptococcal antigen.Adv Exp Med Biol 1992; 327: 15–63.

    Google Scholar 

  18. Macrina, F.L., Dertzbaugh, M.T., Halula, M.C., Krah, E.R. R. 3rd, Jones K.R. Genetic approaches to the study of oral microflora: a review. Crit Rev Oral Biol Med 1990; 1: 207–27.

    Article  CAS  Google Scholar 

  19. Marshall, J.C., The ecology and immunology of the gastrointestinal tract in health and critical illness. Hosp Infect 1991 ;19(Suppl. C):7–17.

    Article  Google Scholar 

  20. Lidbeck A., Nord C.E. Lactobacilli and the normal human anaerobic microflora. Clin Infect Dis 1993;16(Suppl.4):S181–7.

    Article  Google Scholar 

  21. Metchnikoff E. . Recherches sur le cholera et le vibri-ons. Ann Inst Pasteur (Paris) 1894; 8: 529–89.

    Google Scholar 

  22. Rettger L.F., Levy M.N., Weinstein L, Weiss J.E. Lactobacillus acidophilus and its therapeutic application. New Haven, CT: Yale University Press, 1935.

  23. Reid G., Bruce A.W., McGroarty J.A., Cheng K.J., Costerton J.W. Is there a role for lactobacilli in prevention of urogenital and intestinal infections? Clin Microbiol Rev 1990; 3: 335–44.

    Article  CAS  Google Scholar 

  24. Smith H . Virulence determinants of Escherichia coli: Present knowledge and questions. Can J Microbiol 1992; 38: 747–52.

    Article  CAS  Google Scholar 

  25. Wells C.L., Maddaus M.A., Jechorek R.P., Simmons R.L. Role of intestinal anaerobic bacteria in colonization resistance. Eur J Clin Microbiol Infect Dis 1988; 7: 107–13.

    Article  CAS  Google Scholar 

  26. Tazume S., Hashimoto K., Sasaki S . Intestinal flora and bile acid metabolism. Nippon Saikingaku Zassi 1979; 34: 745–54.

    Article  CAS  Google Scholar 

  27. Goncharova. G.L, Semenova L.P., Liannaia A.M., Kozlova E.P., Donskikh E.E. Human bifidobacterium flora, its normalizing and protective functions. Antibiot Med Biotekhnol 1987; 32: 179–83.

    CAS  PubMed  Google Scholar 

  28. Hentges D.J. Inhibition of Shigella by the normal intestinal flora. In: ref. 2.

  29. Hummel R.P., Ostreicher E.J., Maley M.P., MacMil-lan B.G. Inhibition of Candida albicans by Escherichia coll in vitro and in the germfree mouse. J Surg Res 1973; 15: 53–8.

    Article  CAS  Google Scholar 

  30. Gutorova L.D., Karimova D.Kh., Molochaeva I.S., Riazanova A.I., Mukhamadieva M.Kh. Effect of enteroviruses on the ecology of intestinal bacteria. Vopr Virusol 1981; 2: 234–6.

    Google Scholar 

  31. Lasch E.E., Abed Y, Gerichter C.B., Massri M.E., Marcus O., Hensher R., Goldblum N. Results of a program combining live and killed polio vaccines, Isr J Med Sci 1983; 19: 1021–3.

    CAS  PubMed  Google Scholar 

  32. Kelly S., Sanderson W.W., Neidl C. Removal of enteroviruses from sewage by activated sludge. J Water Pollut Contr Fed 1961 ; 33: 1056–62.

    Google Scholar 

  33. Yates M.V., Stetzenbach L.D., Gerba C.P., Sinclair N.A. The effect of indigenous bacteria on virus survival in ground water. J Environ Sci Health 1990; A25: 81–100.

    CAS  Google Scholar 

  34. Voroshilova M.K. Potential use of nonpathogenic enteroviruses for control of human disease. Prog Med Virol 1989; 36: 191–202.

    CAS  PubMed  Google Scholar 

  35. Whitaker-Dowling P., Youngner J.S. Viral interference-dominance of mutant viruses over wildtype virus in mixed infections. Microbiol Rev 1987: 51: 179–191.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Acheson D.W.K. Enterotoxins in acute infective diarrhoea. J Infecf, 1992; 24: 225–45.

    Article  CAS  Google Scholar 

  37. Lerner R.A., Kang A.S., Bain J.D., Burton D.R., Bar-bas C.F. 3d. Antibodies without immunization. Science 1992; 258: 1313–4.

    Article  CAS  Google Scholar 

  38. Bokkenheuser V. The friendly anaerobes. Clin Infect Dis 1993; 16(Suppl.4):S427–34.

    Article  CAS  Google Scholar 

  39. Alving C.R., Swartz G.M. Jr. Antibodies to cholesterol, cholesterol conjugates, and liposomes: implications for atherosclerosis and autoimmunity. Crit Rev Immunol 1991 ; 10: 441–53.

    CAS  PubMed  Google Scholar 

  40. Newman D . The treatment of cystitis by intravesical injections of lactic bacillus cultures. Lancet 1915: 2: 330–32.

    Article  Google Scholar 

  41. Bruce.A.W., Reid G. Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infections. Can J Microbiol 1988: 34: 339–43.

    Article  CAS  Google Scholar 

  42. Spiegel C.A. Bacterial vaginosis. Clin Microbiol Rev 1991: 4: 485–502.

    Article  CAS  Google Scholar 

  43. Friedlander A., Druker M.M., Schachter A. Lactobacillus acidophilus and vitamin B complex in the treatment of vaginal infection. Panminerva Med 1986; 28: 51–3.

    CAS  PubMed  Google Scholar 

  44. Skarin A., Sylwan J. Vaginal lactobacilli inhibiting growth of Gardnerella vaginalis, Mobiluncus, and other bacterial species cultured from vaginal content of women with bacterial vaginosis. Acta Pathol Microbiol Scand Sect B 1986; 94: 399–403.

    CAS  Google Scholar 

  45. Andersch B., Lindell D., Dahlen I., Brandberg A. Bacterial vaginosis and the effect of intermittent prophylactic treatment with an acid lactate gel. Gynecol Obstet Invest 1990; 30: 114–9, erratum in 1991;31:7.

    Article  CAS  Google Scholar 

  46. Polonelli L., Archbusacci C., Sestito M., Morace G. Killer system: a simple method for differentiating Candida albicans strains. J Clin Microbiol 1983: 17: 774–80.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Wickner R.B. Double-stranded and single-stranded RNA viruses of Saccharomyces cerevisiae. Annu Rev Microbiol 1992; 46:34775.

    Article  CAS  Google Scholar 

  48. Tipper D.J., Schmitt M.J. Yeast dsRNA viruses: replication and killer phenotypes. Mol Microbiol 1991: 5: 2331–8.

    Article  CAS  Google Scholar 

  49. Kreiss J., Ngugi E., Holmes K., Ndinya-Achola J., Waiyaki P., Roberts P.L., Ruminjo I., Sajabi R., Kimata J., Fleming T.R. Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA 1992: 268: 477–82.

    Article  CAS  Google Scholar 

  50. Truneh A., Frescatore R.L, Thiem P., Leary J.J., Rosenberg M., Hanna N., Sweet R., Bugelski P.J. Humoral response of cynomolgus macaques to human soluble CD4: antibody reactivity restricted to xeno-human determinants. Cell Immunol 1990; 131: 98–108.

    Article  CAS  Google Scholar 

  51. Reimann K.A., Burkly L.C., Burrus B., Waite B.C., Lord C.I., Letvin N.L. In vivo administration to rhesus monkeys of a CD4-specific monoclonal antibody capable of blocking AIDS virus replication. AIDS Res Hum Retroviruses 1993; 9: 199–207.

    Article  CAS  Google Scholar 

  52. Mohan P. Anti-AIDS drug development: challenges and strategies. Pharm Res 1992; 9: 703–14.

    Article  CAS  Google Scholar 

  53. Levy J.A. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 1993; 57: 183–289.

    CAS  PubMed  PubMed Central  Google Scholar 

  54. Pestka S., Langer J.A., Zoon K.C., Samuel C.E. Interferons and their actions. Annu Rev Biochem 1987- 56: 727–77.

    Article  CAS  Google Scholar 

  55. Leer R.J., van-Luijk N., Posno M., Pouwels P.H. Structural and functional analysis of two cryptic plasmids from Lactobacillus pentosus MD353 and Lactobacillus plan. Mol Gen Genet 1992; 234: 265–74.

    Article  CAS  Google Scholar 

  56. McGroarty J.A., Tomeczek L., Pond D.G., Reid G., Bruce A.W. Hydrogen peroxide production by Lac-tobacillus species: Correlation with susceptibility to the spermicidal compound nonoxynol-9. J Infect Dis 1992: 165: 1142–4.

    Article  CAS  Google Scholar 

  57. Lo S.C., Hayes M.M., Wang R.Y, Pierce P.F., Kotani H., Shih J.W. Newly discovered mycoplasma isolated from patients infected with HIV. Lancet 1991; 338: 1415–8.

    Article  CAS  Google Scholar 

  58. Lenski R.E. Evaluating the fate of genetically modified organisms in the environment: Are they inherently less fit? Experientia 1993; 49: 201–9.

    Article  CAS  Google Scholar 

  59. Pickup R.W., Morgan J.A.W., Winstanley C., Saun-ders J.R. Implications for the release of genetically engineered organisms. J Appl Bact Symp (Suppl) 1991; 70: 19S–30S.

    Google Scholar 

  60. Wickman K. Burn model. In: ref. 2.

  61. Bell G.I., Fong N.M., Stempien M.M., Wormsted M.A., Caput D., Ku L, Urdea M.S., Rail L.B., Sanchez-Pescador R. Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization. Nucleic Acids Res 1986: 14: 8427–46.

    Article  CAS  Google Scholar 

  62. Finch P.W., Rubin J.S., Miki T, Ron D., Aaronson S.A. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 1989: 245: 752–5.

    Article  CAS  Google Scholar 

  63. Kurokawa.T., Sasada R., Iwane M., Igarashi K . Cloning and expression of cDNA encoding human basic fibroblast growth factor. FEBS Lett 1987; 213: 189–94.

    Article  CAS  Google Scholar 

  64. Rail L.B., Scott J., Bell G.I . Human insulin-like growth factor I and II messenger RNA: Isolation of complementary DNA and analysis of expression. Meth Enzymol 1987; 146: 239–48.

    Article  Google Scholar 

  65. Urushizaki Y, Niitsu Y, Terui T., Koshida Y, Mahara K., Kohgo Y, Urushizaki I., Takahashi Y, Ito H . Cloning and expression of the gene for human transforming growth factor-beta in Escherichia coll. Tumor fles 1987; 22: 41–55.

    CAS  Google Scholar 

Download references

Author information

Author notes

  1. Henry Chang: This article does not represent the official views of the US Government.

Authors and Affiliations

  1. a medical officer at the US Food and Drug Administration, HFM-573, 5600 Fishers Lane, Rockville, MD, 20857

    Henry Chang

Authors
  1. Henry Chang
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chang, H. Genetic engineering to enhance microbial interference and related therapeutic applications. Nat Biotechnol 14, 444–447 (1996). https://doi.org/10.1038/nbt0496-444

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nbt0496-444

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing